Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
October 23, 2015 — Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...
October 16, 2015 — Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...
October 15, 2015 — Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...
September 4, 2015 — A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal ...
September 1, 2015 — A bioresorbable drug-eluting coronary stent showed similar efficacy and safety results compared to a ...
September 1, 2015 — Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of ...
August 17, 2015 — The global interventional cardiology devices market is expected to reach $25.16 billion by 2020 ...